Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training
Latest Information Update: 31 Mar 2020
Price :
$35 *
At a glance
- Drugs Vortioxetine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 26 Mar 2020 Primary endpoint (Change in total fluid cognitive score (26 weeks)) has not been met as per Results published in the American Journal of Psychiatry.
- 26 Mar 2020 Primary endpoint (Change in total fluid cognitive score (12 weeks)) has been met as per Results published in the American Journal of Psychiatry.
- 26 Mar 2020 Primary endpoint (Change in total fluid cognitive score (4 weeks)) has not been met as per Results published in the American Journal of Psychiatry.